Efficient promotion of collagen antibody induced arthritis (CAIA) using four monoclonal antibodies specific for the major epitopes recognized in both collagen induced arthritis and rheumatoid arthritis

被引:98
作者
Nandakumar, KS [1 ]
Holmdahl, R [1 ]
机构
[1] Lund Univ, Med Inflammat Res, S-22184 Lund, Sweden
关键词
collagen type II; monoclonal antibodies; arthritis;
D O I
10.1016/j.jim.2005.06.017
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
An antibody response to defined epitopes located on the triple helical portion of type II collagen (CII) is associated with the development of collagen-induced arthritis (CIA) and rheumatoid arthritis (RA). Monoclonal antibodies to epitopes associated with arthritis, but not antibodies specific for epitopes not associated with arthritis, induce arthritis in mice, the so-called collagen antibody induced arthritis (CAIA) model. We have selected monoclonal IgG antibodies specific for four well-defined major epitopes on triple helical CII, the Cl, Jl, D3 and Ul epitopes. These antibodies bind the epitopes specifically as determined using recombinant or synthetic triple helical epitopes. They are encoded from somatically mutated V genes. They all bind cartilage m vivo in normal mice. All of the antibodies induce mild arthritis after injection intravenously and if injected as a cocktail they induce severe clinical arthritis. Intravenous injection of a total of 4 mg antibodies (0.5 mg antibodies per clone) induced arthritis in several different mouse strains without any secondary immune stimulus and intraperitoneal injection of LPS 7 days later dramatically raised the severity. Thus, this method is recommended as a new protocol for the induction of CAIA. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:126 / 136
页数:11
相关论文
共 52 条
[1]   Arthritogenic anti-type II collagen antibodies are pathogenic for cartilage-derived chondrocytes independent of inflammatory cells [J].
Amirahmadi, SF ;
Whittingham, S ;
Crombie, DE ;
Nandakumar, KS ;
Holmdahl, R ;
Mackay, IR ;
van Damme, MP ;
Rowley, MJ .
ARTHRITIS AND RHEUMATISM, 2005, 52 (06) :1897-1906
[2]   An arthritogenic monoclonal antibody to type II collagen, CII-C1, impairs cartilage formation by cultured chondrocytes [J].
Amirahmadi, SF ;
Pho, MH ;
Gray, RE ;
Crombie, DE ;
Whittingham, SF ;
Zuasti, BB ;
Van Damme, MP ;
Rowley, MJ .
IMMUNOLOGY AND CELL BIOLOGY, 2004, 82 (04) :427-434
[3]   EXPRESSION OF A TRANSGENIC CLASS-II AB GENE CONFERS SUSCEPTIBILITY TO COLLAGEN-INDUCED ARTHRITIS [J].
BRUNSBERG, U ;
GUSTAFSSON, K ;
JANSSON, L ;
MICHAELSSON, E ;
AHRLUND-RICHTER, L ;
PETTERSSON, S ;
MATTSSON, R ;
HOLMDAHL, R .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (07) :1698-1702
[4]   Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse [J].
Burkhardt, H ;
Koller, T ;
Engström, Å ;
Nandakumar, KS ;
Turnay, J ;
Kraetsch, HG ;
Kalden, JR ;
Holmdahl, R .
ARTHRITIS AND RHEUMATISM, 2002, 46 (09) :2339-2348
[5]   Collagen-induced arthritis development requires αβ T cells but not γδ T cells:: studies with T cell-deficient (TCR mutant) mice [J].
Corthay, A ;
Johansson, Å ;
Vestberg, M ;
Holmdahl, R .
INTERNATIONAL IMMUNOLOGY, 1999, 11 (07) :1065-1073
[6]   Measurement of antibodies to collagen II by inhibition of collagen fibril formation in vitro [J].
Gray, RE ;
Seng, N ;
Mackay, LR ;
Rowley, MJ .
JOURNAL OF IMMUNOLOGICAL METHODS, 2004, 285 (01) :55-61
[7]   Joint damage and inflammation in c-Jun N-terminal kinase 2 knockout mice with passive murine collagen-induced arthritis [J].
Han, ZN ;
Chang, LF ;
Yamanishi, Y ;
Karin, M ;
Firestein, GS .
ARTHRITIS AND RHEUMATISM, 2002, 46 (03) :818-823
[8]   Complement activation by both classical and alternative pathways is critical for the effector phase of arthritis [J].
Hietala, MA ;
Nandakumar, KS ;
Persson, L ;
Fahlén, S ;
Holmdahl, R ;
Pekna, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (04) :1208-1216
[9]   MULTIPLE EPITOPES ON CARTILAGE TYPE-II COLLAGEN ARE ACCESSIBLE FOR ANTIBODY-BINDING INVIVO [J].
HOLMDAHL, R ;
MO, JA ;
JONSSON, R ;
KARLSTROM, K ;
SCHEYNIUS, A .
AUTOIMMUNITY, 1991, 10 (01) :27-34
[10]  
HOLMDAHL R, 1989, J IMMUNOL, V142, P1881